FTC finalizes settlement on melanoma app


MelApp and Mole Detective agreed to no longer make claims that the Federal Trade Commission said weren’t corroborated by scientific evidence. The F TC voted 4-1 to give final approval to a settlement regarding claims made by Health Discovery Corporation, the developer of MelApp, which claimed to help people detect